Validity and reliability of a new tool to evaluate handwriting difficulties in Parkinson's disease

PLoS One. 2017 Mar 2;12(3):e0173157. doi: 10.1371/journal.pone.0173157. eCollection 2017.

Abstract

Background: Handwriting in Parkinson's disease (PD) features specific abnormalities which are difficult to assess in clinical practice since no specific tool for evaluation of spontaneous movement is currently available.

Objective: This study aims to validate the 'Systematic Screening of Handwriting Difficulties' (SOS-test) in patients with PD.

Methods: Handwriting performance of 87 patients and 26 healthy age-matched controls was examined using the SOS-test. Sixty-seven patients were tested a second time within a period of one month. Participants were asked to copy as much as possible of a text within 5 minutes with the instruction to write as neatly and quickly as in daily life. Writing speed (letters in 5 minutes), size (mm) and quality of handwriting were compared. Correlation analysis was performed between SOS outcomes and other fine motor skill measurements and disease characteristics. Intrarater, interrater and test-retest reliability were assessed using the intraclass correlation coefficient (ICC) and Spearman correlation coefficient.

Results: Patients with PD had a smaller (p = 0.043) and slower (p<0.001) handwriting and showed worse writing quality (p = 0.031) compared to controls. The outcomes of the SOS-test significantly correlated with fine motor skill performance and disease duration and severity. Furthermore, the test showed excellent intrarater, interrater and test-retest reliability (ICC > 0.769 for both groups).

Conclusion: The SOS-test is a short and effective tool to detect handwriting problems in PD with excellent reliability. It can therefore be recommended as a clinical instrument for standardized screening of handwriting deficits in PD.

Publication types

  • Validation Study

MeSH terms

  • Case-Control Studies
  • Cross-Sectional Studies
  • Female
  • Handwriting*
  • Humans
  • Male
  • Parkinson Disease / physiopathology*

Grants and funding

The project was funded by the Research Foundation – Flanders (FWO) with grant number G.0906.11. In addition, EN and SB are research assistents, EH is a postdoctoral researcher and WV a senior clinical investigator of the FWO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.